Published in Am J Med Genet B Neuropsychiatr Genet on January 05, 2005
The need for speed: an update on methamphetamine addiction. J Psychiatry Neurosci (2006) 2.46
Molecular genetics of addiction and related heritable phenotypes: genome-wide association approaches identify "connectivity constellation" and drug target genes with pleiotropic effects. Ann N Y Acad Sci (2008) 1.69
"Higher order" addiction molecular genetics: convergent data from genome-wide association in humans and mice. Biochem Pharmacol (2007) 1.22
Methamphetamine use parameters do not predict neuropsychological impairment in currently abstinent dependent adults. Drug Alcohol Depend (2009) 1.08
Methamphetamine-associated psychosis. J Neuroimmune Pharmacol (2011) 1.05
Genetic variants in brain-derived neurotrophic factor associated with Alzheimer's disease. J Med Genet (2007) 1.03
Impact of the brain-derived neurotrophic factor Val66Met polymorphism on levels of hippocampal N-acetyl-aspartate assessed by magnetic resonance spectroscopic imaging at 3 Tesla. Biol Psychiatry (2008) 0.90
Gender, brain-derived neurotrophic factor Val66Met, and frequency of methamphetamine use. Gend Med (2012) 0.87
Advances in genetic studies of substance abuse in China. Shanghai Arch Psychiatry (2013) 0.81
Role of Brain-Derived Neurotrophic Factor in Beneficial Effects of Repetitive Transcranial Magnetic Stimulation for Upper Limb Hemiparesis after Stroke. PLoS One (2016) 0.81
Changes in serum BDNF levels associated with moderate-intensity exercise in healthy young Japanese men. Springerplus (2013) 0.78
CNS genes implicated in relapse. Subst Abuse (2008) 0.77
Contribution of BDNF and DRD2 genetic polymorphisms to continued opioid use in patients receiving methadone treatment for opioid use disorder: an observational study. Addict Sci Clin Pract (2015) 0.76
Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial. Lancet Oncol (2009) 21.94
Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet (2008) 10.52
Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry (2003) 3.12
Calcium signals: the lead currency of plant information processing. Plant Cell (2010) 2.87
Microglial activation and dopamine terminal loss in early Parkinson's disease. Ann Neurol (2005) 2.77
Oral care reduces pneumonia in older patients in nursing homes. J Am Geriatr Soc (2002) 2.68
Alpha-CaMKII deficiency causes immature dentate gyrus, a novel candidate endophenotype of psychiatric disorders. Mol Brain (2008) 2.55
Multicolor bimolecular fluorescence complementation reveals simultaneous formation of alternative CBL/CIPK complexes in planta. Plant J (2008) 2.44
Increased serum levels of glutamate in adult patients with autism. Prog Neuropsychopharmacol Biol Psychiatry (2006) 2.42
Antibody-dependent cellular cytotoxicity mediated by cetuximab against lung cancer cell lines. Clin Cancer Res (2007) 2.31
Ifenprodil for the treatment of flashbacks in female posttraumatic stress disorder patients with a history of childhood sexual abuse. Biol Psychiatry (2011) 2.16
Ethnic difference of the BDNF 196G/A (val66met) polymorphism frequencies: the possibility to explain ethnic mental traits. Am J Med Genet B Neuropsychiatr Genet (2004) 2.13
Frequent EGFR mutations in brain metastases of lung adenocarcinoma. Int J Cancer (2006) 2.11
Increased levels of glutamate in brains from patients with mood disorders. Biol Psychiatry (2007) 2.05
Adolescent stress-induced epigenetic control of dopaminergic neurons via glucocorticoids. Science (2013) 2.04
Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia. Hum Mol Genet (2004) 1.95
Inducible protein knockout reveals temporal requirement of CaMKII reactivation for memory consolidation in the brain. Proc Natl Acad Sci U S A (2003) 1.93
Decreased serum levels of D-serine in patients with schizophrenia: evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia. Arch Gen Psychiatry (2003) 1.93
Brain serotonin transporter density and aggression in abstinent methamphetamine abusers. Arch Gen Psychiatry (2006) 1.93
Genome-wide association study of schizophrenia in a Japanese population. Biol Psychiatry (2010) 1.89
Fabp7 maps to a quantitative trait locus for a schizophrenia endophenotype. PLoS Biol (2007) 1.88
Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: a neurodevelopmental animal model of schizophrenia. Biol Psychiatry (2005) 1.85
Impact of the DISC1 Ser704Cys polymorphism on risk for major depression, brain morphology and ERK signaling. Hum Mol Genet (2006) 1.82
Critical role of brain-derived neurotrophic factor in mood disorders. Brain Res Brain Res Rev (2004) 1.82
A ubiquitin-10 promoter-based vector set for fluorescent protein tagging facilitates temporal stability and native protein distribution in transient and stable expression studies. Plant J (2010) 1.75
Genome-wide association for methamphetamine dependence: convergent results from 2 samples. Arch Gen Psychiatry (2008) 1.72
Approximate entropy of human respiratory movement during eye-closed waking and different sleep stages. Chest (2003) 1.72
The serotonin 1A receptor gene confer susceptibility to mood disorders: results from an extended meta-analysis of patients with major depression and bipolar disorder. Eur Arch Psychiatry Clin Neurosci (2012) 1.70
Measurement of Pseudomonas aeruginosa multidrug efflux pumps by quantitative real-time polymerase chain reaction. FEMS Microbiol Lett (2005) 1.63
Diacylglycerol kinase zeta inhibits G(alpha)q-induced atrial remodeling in transgenic mice. Heart Rhythm (2008) 1.54
Brain serotonin and dopamine transporter bindings in adults with high-functioning autism. Arch Gen Psychiatry (2010) 1.53
A two-stage case-control association study of the dihydropyrimidinase-like 2 gene (DPYSL2) with schizophrenia in Japanese subjects. J Hum Genet (2010) 1.52
Effectiveness of milnacipran for the treatment of chronic pain in the orofacial region. Clin Neuropharmacol (2010) 1.51
Copy number variation in schizophrenia in the Japanese population. Biol Psychiatry (2009) 1.49
DNA methylation profiles of the brain-derived neurotrophic factor (BDNF) gene as a potent diagnostic biomarker in major depression. PLoS One (2011) 1.48
Microglial activation in schizophrenia and minocycline treatment. Prog Neuropsychopharmacol Biol Psychiatry (2008) 1.47
Effectiveness of Information Technology Aided Relapse Prevention Programme in Schizophrenia excluding the effect of user adherence: a randomized controlled trial. Schizophr Res (2013) 1.45
The involvement of glucocorticoids in psychological stress-induced exacerbations of experimental allergic asthma. Int Arch Allergy Immunol (2014) 1.43
Association of dopamine transporter loss in the orbitofrontal and dorsolateral prefrontal cortices with methamphetamine-related psychiatric symptoms. Am J Psychiatry (2003) 1.41
What is a rational antidepressant treatment for major depression in patients with Parkinson's disease? Psychiatry Clin Neurosci (2012) 1.41
Regional differences in extracellular dopamine and serotonin assessed by in vivo microdialysis in mice lacking dopamine and/or serotonin transporters. Neuropsychopharmacology (2004) 1.41
Childhood-onset schizophrenia and tryptophan hydroxylase gene polymorphism. Am J Med Genet B Neuropsychiatr Genet (2004) 1.40
Evaluating the state dependency of the Temperament and Character Inventory dimensions in patients with major depression: a methodological contribution. J Affect Disord (2002) 1.38
Zonisamide-induced depression and mania in patients with epilepsy. J Clin Psychopharmacol (2004) 1.38
Decreased serum levels of mature brain-derived neurotrophic factor (BDNF), but not its precursor proBDNF, in patients with major depressive disorder. PLoS One (2012) 1.36
High occupancy of sigma-1 receptors in the human brain after single oral administration of fluvoxamine: a positron emission tomography study using [11C]SA4503. Biol Psychiatry (2007) 1.33
Correlation between Asian dust storms and worsening asthma in Western Japan. Allergol Int (2011) 1.30
Synthesis and biological evaluation of D-amino acid oxidase inhibitors. J Med Chem (2008) 1.29
A variant C178T in the regulatory region of the serotonin receptor gene HTR3A modulates neural activation in the human amygdala. J Neurosci (2005) 1.28
NMDA- and beta-amyloid1-42-induced neurotoxicity is attenuated in serine racemase knock-out mice. J Neurosci (2008) 1.27
Co-administration of a D-amino acid oxidase inhibitor potentiates the efficacy of D-serine in attenuating prepulse inhibition deficits after administration of dizocilpine. Biol Psychiatry (2009) 1.27
Association of AKT1 with schizophrenia confirmed in a Japanese population. Biol Psychiatry (2004) 1.26
Brain neuronal CB2 cannabinoid receptors in drug abuse and depression: from mice to human subjects. PLoS One (2008) 1.26
Genome-wide association study implicates NDST3 in schizophrenia and bipolar disorder. Nat Commun (2013) 1.25
Reduced D-serine to total serine ratio in the cerebrospinal fluid of drug naive schizophrenic patients. Prog Neuropsychopharmacol Biol Psychiatry (2005) 1.24
Potentiation of nerve growth factor-induced neurite outgrowth by fluvoxamine: role of sigma-1 receptors, IP3 receptors and cellular signaling pathways. PLoS One (2008) 1.24
NrCAM in addiction vulnerability: positional cloning, drug-regulation, haplotype-specific expression, and altered drug reward in knockout mice. Neuropsychopharmacology (2006) 1.24
Reduced serum levels of brain-derived neurotrophic factor in adult male patients with autism. Prog Neuropsychopharmacol Biol Psychiatry (2006) 1.23
D-Serine and a glycine transporter inhibitor improve MK-801-induced cognitive deficits in a novel object recognition test in rats. Behav Brain Res (2007) 1.23
Identification of YWHAE, a gene encoding 14-3-3epsilon, as a possible susceptibility gene for schizophrenia. Hum Mol Genet (2008) 1.23